Study of Natalizumab in Relapsed/Refractory Multiple Myeloma

This study has been terminated.

Study NCT00675428 Information provided by Biogen Idec

First Received: May 6, 2008 Last Updated: January 6, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2010
Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)